Kiniksa Pharmaceuticals International (KNSA) Inventory (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Inventory came in at $70.9 million in Q2 2026, up 47.22% YoY from $48.2 million in Q2 2025, and down 3.02% on a QoQ basis from $73.1 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Inventory (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Inventory data on file, last reported at $70.9 million in Q2 2026.
- Quarterly Inventory rose 47.22% year-over-year to $70.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $70.9 million (up 47.22% YoY) and the FY2025 annual result came in at $54.9 million, up 108.22% from the prior year.
- Inventory eased to $70.9 million in Q2 2026, from $73.1 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $73.1 million in Q1 2026 to a low of $13.2 million in Q1 2022.
- A 5-year average of $33.4 million and a median of $26.8 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory soared 504.07% — and 2025, when it slipped 19.1%.
- Tracing KNSA's Inventory over 5 years: stood at $21.6 million in 2022, then soared by 44.09% to $31.1 million in 2023, then fell by 15.29% to $26.4 million in 2024, then soared by 108.22% to $54.9 million in 2025, then advanced by 29.21% to $70.9 million in 2026.
- The last three Inventory figures came in at $70.9 million (Q2 2026), $73.1 million (Q1 2026), and $54.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 816.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.07 Bn | 5.54 Bn | 220.03 Mn | 70.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.93 Mn |
| Mar 31, 2026 | 73.14 Mn |
| Dec 31, 2025 | 54.90 Mn |
| Sep 30, 2025 | 41.40 Mn |
| Jun 30, 2025 | 48.18 Mn |
| Mar 31, 2025 | 22.07 Mn |
| Dec 31, 2024 | 26.36 Mn |
| Sep 30, 2024 | 28.68 Mn |
| Jun 30, 2024 | 34.86 Mn |
| Mar 31, 2024 | 27.28 Mn |
| Dec 31, 2023 | 31.12 Mn |
| Sep 30, 2023 | 25.58 Mn |
| Jun 30, 2023 | 23.96 Mn |
| Mar 31, 2023 | 23.43 Mn |
| Dec 31, 2022 | 21.60 Mn |
| Sep 30, 2022 | 14.62 Mn |
| Jun 30, 2022 | 19.92 Mn |
| Mar 31, 2022 | 13.22 Mn |
| Dec 31, 2021 | 3.68 Mn |
| Sep 30, 2021 | 5.61 Mn |